Refine
Year of publication
Document Type
- Preprint (718)
- Article (703)
- Working Paper (6)
- Conference Proceeding (3)
- Doctoral Thesis (3)
- Report (2)
Has Fulltext
- yes (1435)
Is part of the Bibliography
- no (1435)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- COVID-19 (4)
- Cancer (4)
- Collective Flow (4)
- Depression (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Biomarkers (3)
- Epilepsy (3)
- Genetics (3)
- Heavy Ions (3)
- Heavy Quark Production (3)
- Jets and Jet Substructure (3)
- Magnetic resonance imaging (3)
- Seizure (3)
- acute myeloid leukemia (3)
- pp collisions (3)
- Accelerators & Beams (2)
- Acute myeloid leukemia (2)
- Algorithms (2)
- Artificial intelligence (2)
- Atomic, Molecular & Optical (2)
- Beauty production (2)
- Biomarker (2)
- Bipolar disorder (2)
- Bone density (2)
- CT (2)
- CV9202 (2)
- Charm physics (2)
- Cohort studies (2)
- Collectivity (2)
- Correlation (2)
- Costs (2)
- Diffraction (2)
- Elastic scattering (2)
- Elliptic flow (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- FGFR (2)
- Frieden (2)
- Friedenskonferenz (2)
- Heavy-ion collisions (2)
- Immunology (2)
- Intensive care units (2)
- Lepton-Nucleon Scattering (experiments) (2)
- MRI (2)
- MSC (2)
- MSC2013 (2)
- Mitochondria (2)
- Multidetector computed tomography (2)
- München (2)
- Neoplasms (2)
- Non-small cell lung cancer (2)
- Oncology (2)
- Osteoporosis (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Pre-analytics (2)
- Psychiatric disorders (2)
- QCD (2)
- Quality of life (2)
- Quarkonium (2)
- Relativistic heavy-ion collisions (2)
- SARS-CoV-2 (2)
- Shear viscosity (2)
- Sicherheitskonferenz (2)
- Single electrons (2)
- Spine (2)
- Surgery (2)
- Tomography (2)
- Tomography (x-ray computed) (2)
- apoptosis (2)
- cabozantinib (2)
- childhood acute myeloid leukemia (2)
- computed tomography (2)
- growth inhibition (2)
- immunotherapy (2)
- land use (2)
- liver (2)
- lung cancer (2)
- penile cancer (2)
- portal hypertension (2)
- relapse (2)
- resistant cell lines (2)
- salvage therapy (2)
- security conference (2)
- squamous cell carcinoma (2)
- storage rings (2)
- targeted therapy (2)
- 19F (1)
- 3 mm RAS instruments (1)
- 3 mm instruments (1)
- 3years (1)
- 900 GeV (1)
- ABCB1 (1)
- ABCC1 (1)
- ABCG2 (1)
- ACLF (1)
- ADGRE1 (1)
- AKI (1)
- AKT (1)
- ALICE detector (1)
- ALK-rearranged NSCLC (1)
- APRI (1)
- Ablation Techniques (1)
- Accelerators & storage rings (1)
- Acquired drug resistance (1)
- Acquired resistance (1)
- Active middle ear implants (1)
- Acuris (1)
- Acute lymphoblastic leukemia (1)
- Acute lymphocytic leukaemia (1)
- Adolescents (1)
- Age determination by skeleton (1)
- Age groups (1)
- Aktienmarkt (1)
- Alpha-synuclein (1)
- Alternative oxidase (1)
- Alzheimer (1)
- Amino acid analysis (1)
- Amyloid precursor protein (1)
- Anemia (1)
- Angiography (1)
- Angiomyolipoma (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Anticonvulsant (1)
- Antifungal agents (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Aortic valve replacement (1)
- Applikationen (1)
- Archaeogeophysics (1)
- Artificial Intelligence (1)
- Aspergillosis (1)
- Atomic & molecular beams (1)
- Auditory system (1)
- Autofreies Wohnen (1)
- Autologous stem cell transplantation (1)
- Automated Tube Potential Selection (1)
- Autoreduziertes Wohnen (1)
- Awareness campaign (1)
- B cell receptor (1)
- B-slope (1)
- BI1361849 (1)
- Beam loss (1)
- Behavior (1)
- Behavioral disorders (1)
- Bike-Sharing (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biogeochemistry (1)
- Biological heart valves (1)
- Biomonitoring (1)
- Bioprosthesis (1)
- Biopsy (1)
- Bleeding (1)
- Blood (1)
- Blood sample handling (1)
- Bloodstream infections (1)
- Bone conduction devices (1)
- Bone diseases, Metabolic (1)
- Bone marrow (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brachiopoda (1)
- Brachiozoa (1)
- Breathing (1)
- Bryozoa (1)
- Business strategy in drug development (1)
- C-reactive protein (1)
- CABG (1)
- CAD/ CAM crown (1)
- CAKUT (1)
- CNDAC (1)
- COMT (1)
- CRPC (1)
- CT dual-energy computed tomography (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CT-guidance (1)
- CTLA-4 (1)
- Calcium (1)
- Cancer Staging (1)
- Cancer check up (1)
- Cancer staging (1)
- Car-Sharing (1)
- Carbon cycle (1)
- Cardiac surgery (1)
- Carsharing (1)
- Cell membranes (1)
- Central Europe (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Charge-transfer collisions (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Checkpoint inhibitor (1)
- Chemicals of emerging concern (1)
- Chemoembolization (1)
- Chemotherapy (1)
- Child abuse (1)
- Childhood abuse (1)
- Children (1)
- Chondral Lesion (1)
- Circular accelerators (1)
- Cirrhosis (1)
- Cleanliness level (1)
- Climate-change ecology (1)
- Clinical genetics (1)
- Clinical trial (1)
- Clinical variation (1)
- Coalescence (1)
- Cochlear implantation (1)
- Cold nuclear matter effects (1)
- Collective Flow, (1)
- Colon capsule endoscopy (1)
- Combined immune checkpoint blockade (1)
- Combo® DTS (1)
- Community ecology (1)
- Comparison with QCD (1)
- Complementation rate (1)
- Complex II (1)
- Complex posttraumatic stress disorder (1)
- Compositional bias (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computed tomography, X-ray (1)
- Computer-aided drug design (1)
- Cone-beam computed tomography (1)
- Congenital anomalies (1)
- Consensus statement (1)
- Conservation (1)
- Conservation biology (1)
- Contrast agent (1)
- Couch tracking (1)
- Critical point (1)
- Cryoelectron microscopy (1)
- DCK (1)
- DME (1)
- DNA sequence analysis (1)
- DNA taxonomy (1)
- DNA-PAINT (1)
- DSM (1)
- Darmstadt (1)
- Data sharing (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Diagnostic imaging (1)
- Diagnostic markers (1)
- Dialectical behavioural therapy (1)
- Digitization (1)
- Direct oral anticoagulation (1)
- Direct reactions (1)
- Drug screens (1)
- Drug therapy (1)
- Dual-Source CT (1)
- Dual-energy computed tomography (1)
- EGFR (1)
- EMR1 (1)
- ETP-ALL (1)
- East–west divide (1)
- Eating disorders (1)
- Ecological modelling (1)
- Ecological networks (1)
- Ecosystem ecology (1)
- Ectoprocta (1)
- Edema (1)
- Elderly (1)
- Electric stimulation (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Electroweak interaction (1)
- Elektromobilität (1)
- Ellenberg indicator values (1)
- Embryos (1)
- Endocannabinoids (1)
- Environmental impact (1)
- European stock markets (1)
- Europäische Aktienmärkte (1)
- Europäische Union (1)
- Everolimus (1)
- Evidence-based guidelines (1)
- Exudates and transudates (1)
- Eye movements (1)
- F4/80 (1)
- FBS (1)
- FFLU (1)
- FIB-4 (1)
- FLT3 (1)
- Facial nerve (1)
- Fahrradverleihsysteme (1)
- Feasibility studies (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Flottenkonzepte (1)
- Forest ecology (1)
- Forschung (1)
- Frailty (1)
- Full waveform (1)
- Functional outcomes (1)
- GPS collar (1)
- GWAS (1)
- Gene expression (1)
- General practitioners (1)
- Gimbaled tracking (1)
- Glioblastoma survival (1)
- Global positioning system (1)
- Gram negative bacteria (1)
- Groomed jet radius (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- HBT (1)
- HBV (1)
- HCC (1)
- HIV (1)
- HIV-1 (1)
- HNO (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronization (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Head and neck cancer (1)
- Health information (1)
- Health policy (1)
- Health-seeking behaviour (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion collisions (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Hedgehog pathway (1)
- Helpline (1)
- Hematologic malignancies (1)
- Hematology (1)
- Hematopoietic stem cell transplantation (1)
- Hepatitis C virus (1)
- Herbaria (1)
- Herniated disk (1)
- Hif-1 alpha (1)
- High-dose chemotherapy (1)
- Higher moments (1)
- Hodgkin lymphoma (1)
- Hsp70 (1)
- Hypertension (1)
- Hypochondriasis (1)
- Hypofractionated radiotherapy (1)
- ICL (1)
- ICL V4c (1)
- IHC (1)
- ILUVIEN (1)
- INR (1)
- Image processing (1)
- Image processing (computer-assisted) (1)
- Immunogenetics (1)
- Immunomonitoring (1)
- In-TIPS thrombosis (1)
- Inclusive spectra (1)
- Incomplete colonoscopy (1)
- Inflammation (1)
- Intensity interferometry (1)
- Interference fragmentation function (1)
- International normalized ratio (1)
- Interpretation (1)
- Intervertebral disc displacement (1)
- Intrinsic resistance (1)
- Invariant Mass Distribution (1)
- Invasive candidiasis (1)
- Inversion (1)
- Ionisation energy loss (1)
- Ipilimumab (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- K3EDTA plasma sampling (1)
- KDIGO (1)
- Kidney (1)
- Knockout (1)
- Kryptrochozoa (1)
- LVSPE (1)
- Ladeinfrastruktur (1)
- Lehre (1)
- Lenalidomide (1)
- Leukemia (1)
- Leukemias (1)
- Library screening (1)
- Lincoln-Siedlung (1)
- Lipidol (1)
- Lipidomics (1)
- Liver (1)
- Liver diseases (1)
- Liver transplantation (1)
- Local control (1)
- Lophophorata (1)
- Low & intermediate-energy accelerators (1)
- Low volume prep (1)
- Low-molecular-weight heparin (1)
- Luciferase (1)
- MALAT1 (1)
- MEDIC (1)
- MLC tracking (1)
- MTOR inhibitor (1)
- MYC (1)
- Mass spectrometry (1)
- Mastoiditis (1)
- Material budget (1)
- Medical Oncology (1)
- Melanoma (1)
- Mental health and psychiatry (1)
- Meriç River (1)
- Metabolomics (1)
- Metastasis (1)
- Micropollutants (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mitfahrangebote (1)
- Mitochondrial disease (1)
- Mitoxantrone (1)
- Mixed hearing loss (1)
- Mixture risk assessment (1)
- Mobil-Stationen (1)
- Mobilität (1)
- Mobilitätskonzept (1)
- Mobilitätsstationen (1)
- Mobilitätsverhalten (1)
- Model of evolution (1)
- Molecular diagnostic testing (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multidetector Computed Tomography (1)
- Multifaktorenmodelle (1)
- Multimodalität (1)
- Multiple factor models (1)
- Multiple myeloma (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Mutation databases (1)
- Mycoses (1)
- Myocarditis (1)
- Myopia (1)
- NAFLD (1)
- NK cells (1)
- NMR spectroscopy (1)
- NOTCH (1)
- NOTCH1 (1)
- NSF (1)
- NVBP (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Neural network (1)
- Neuronal morphology (1)
- Neuroscience (1)
- Neutropenia (1)
- Nivolumab (1)
- Nuclear modification factor (1)
- Nuclear reactions (1)
- Nuclear structure & decays (1)
- Nucleon induced nuclear reactions (1)
- ORL (1)
- Obsessive-compulsive disorder (1)
- Oldest-old (1)
- Organ motion (1)
- Osteoporotic fractures (1)
- Otorhinolaryngology (1)
- Oxidative phosphorylation (1)
- Oxygen (1)
- PD-1 (1)
- PD-L1 (1)
- PLX4032 (1)
- PLX4720 (1)
- PRoMPT (1)
- PSA screening (1)
- PSA-Screening (1)
- PTEN (1)
- PYTHIA (1)
- Parken (1)
- Parkinson’s disease (1)
- Particle and Resonance Production (1)
- Patellofemoral Joint (1)
- Patterns of care (1)
- Pb–Pb (1)
- Pedelecs (1)
- Personenmobilität (1)
- Phakic (1)
- Phantoms (imaging) (1)
- Phoronida (1)
- Phosphate (1)
- Phospho-soda (1)
- Phosphorylation (1)
- Photon counting (1)
- Phylloscopidae (1)
- Phylloscopus (1)
- Phylogeography (1)
- PillCamColon2 (1)
- Plasma (1)
- Point-of-care testing (1)
- Polarization (1)
- Polyps (1)
- Polysomnography (1)
- Polyzoa (1)
- Positive fluid balance (1)
- Positron emission tomography (1)
- Post-traumatic stress disorder (1)
- Postoperative atrial fibrillation (1)
- Preventive medicine (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Prostata-specific antigen (1)
- Prostataspezifisches Antigen (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Prävention (1)
- Psoriasis vulgaris (1)
- Psychological and psychosocial issues (1)
- Pulmonary embolism (1)
- QGP (1)
- QSARs (1)
- Quantitative Imaging (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- RHIC (1)
- RNA (1)
- RNA, long noncoding (1)
- RNActive (1)
- RSL curve (1)
- Radiation detectors (1)
- Radical prostatectomy (1)
- Radiology (1)
- Radiomics (1)
- Radiotherapy (1)
- Randomised controlled trial (1)
- Rapidity Range (1)
- Rare diseases (1)
- Region Rhein-Main (1)
- Registries (1)
- Rehabilitation (1)
- Relapse (1)
- Relativistic heavy ion physics (1)
- Renal cell carcinoma (1)
- Research (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Respiration (1)
- Respiratory chain (1)
- Retro-IDEAL (1)
- Retrospective studies (1)
- Retrospective study (1)
- Rhabdomyoma (1)
- Ribosome (1)
- Risk drivers (1)
- River pollution (1)
- Robotic tracking (1)
- SAMHD1 (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SCCHN (1)
- SLC20A1 (1)
- SMAD (1)
- SPSS (1)
- STIR (1)
- Salivary gland carcinoma (1)
- Sampling protocol (1)
- Sapacitabine (1)
- Second-line treatment (1)
- Seicercus (1)
- Semantics (1)
- Senescence (1)
- Sequence (1)
- Serum (1)
- Shell model (1)
- Single muons (1)
- Sleep (1)
- Sleep deprivation (1)
- Small molecules (1)
- Social anxiety disorder (1)
- Sociodemographic characteristics (1)
- SoftDrop (1)
- Specialist training (1)
- Spectroscopic factors & electromagnetic moments (1)
- Spinal fractures (1)
- Spine density (1)
- Splitting function (1)
- Stenotrophomonas maltophilia (1)
- Steroid (1)
- Subependymal giant cell astrocytoma (1)
- Surface waters (1)
- Surveys (1)
- Survival analysis (1)
- Survival data (1)
- Systematic Uncertainty (1)
- Systemic treatment (1)
- T-ALL (1)
- TGFβ (1)
- TGR(mREN2)27 (1)
- TIPS (1)
- TP53 mutation status (1)
- TR (1)
- TSC (1)
- Target screening (1)
- Targeted therapy (1)
- Taxonomy (1)
- Teaching (1)
- Technical data (1)
- Telemedicine (1)
- Territorial songs (1)
- Therapeutic anticoagulation (1)
- Thermal model (1)
- Time Projection Chamber (1)
- Tracking (1)
- Traditional Chinese Medicine (TCM) (1)
- Transcriptome analysis (1)
- Transition radiation detector (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Transverse momentum (1)
- Transversity (1)
- Treatment (1)
- Trigger (1)
- Tyrosine kinase inhibitor mTOR inhibition (1)
- USP28 (1)
- Umweltbilanz (1)
- University hospitals (1)
- Universitätskliniken (1)
- Urinary continence (1)
- Urinary incontinence (1)
- Ursus arctos (1)
- Uveal melanoma (1)
- VEGFR (1)
- Vaccination (1)
- Valve surgery (1)
- Vasculitis (1)
- Vector Boson Production (1)
- Vemurafenib (1)
- Vesicles (1)
- Vincristine (1)
- Virtual noncalcium reconstructions (1)
- Vorsorgeuntersuchung (1)
- Weiterbildung (1)
- Western diet (1)
- Wohnumzug (1)
- X-ray computed (1)
- X-rays (1)
- Xenon-based gas mixture (1)
- abdominal imaging (1)
- accessory proteins (1)
- acoustic radiation force impulse imaging (1)
- activity sensors (1)
- acute decompensation (1)
- acute lymphoblastic leukemia (1)
- acute-on-chronic liver failure (1)
- adjuvant chemotherapy (1)
- aegean (1)
- age (1)
- amino acids (1)
- amphiregulin (1)
- amygdalin (1)
- anaplastic large cell lymphoma (1)
- angiography (1)
- anterior chamber depth changes (1)
- anti-EGFR therapy (1)
- antiepileptic drugs (1)
- antimicrobial stewardship (1)
- antiviral therapy (1)
- aortic stenosis (1)
- archeological sea-level limiting points (1)
- artesunate (ART) (1)
- artifacts (1)
- artificial intelligence (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- autophagy (1)
- bacterial leakage (1)
- beads (1)
- bioactivity testing (1)
- biogeographic legaciese (1)
- bioindication (1)
- biomarker (1)
- bladder cancer (BCa) (1)
- bladder exstrophy-epispadias complex (1)
- breast cancer (1)
- brown bear (1)
- c-MET (1)
- cabazitaxel (1)
- carbapenem resistance (1)
- cardiac arrest (1)
- cardiac remodeling (1)
- case study (1)
- castration resistance (1)
- cataract surgery (1)
- cell lines (1)
- cell therapy (1)
- cell-free protein synthesis (1)
- characteristic species (1)
- chemorefractory metastatic colorectal cancer (1)
- children and adolescents (1)
- chronic total occlusion (1)
- cilia (1)
- cirrhosis (1)
- cisplatin resistance (1)
- cloacal malformation (1)
- coastal geomorphology (1)
- colorectal cancer (1)
- complementary/alternative medicine (CAM) (1)
- computer tomography (1)
- computer-assisted (1)
- conical coupling (1)
- conometric connection (1)
- corneas (1)
- cryptic species (1)
- cytarabine dose (1)
- dE/dx (1)
- data quality (1)
- depression (1)
- deswelling (1)
- detector (1)
- diagnostic imaging (1)
- differentiating species (1)
- disease prevalence (1)
- docetaxel (1)
- docetaxel (DX) resistance (1)
- drug resistance (1)
- dual-energy (1)
- easyPACId (1)
- ectosomes (1)
- effective lens position (1)
- elderly (1)
- electrical resistivity tomography (1)
- electroencephalography (EEG) (1)
- eltrombopag (1)
- energy-dispersive x-ray spectroscopy (1)
- epigenomics (1)
- epiregulin (1)
- ethical trade-off (1)
- eutrophication (1)
- excitation (1)
- exosomes (1)
- experimental results (1)
- explainable AI (1)
- extinction (1)
- extracellular vesicles (1)
- fear conditioning (1)
- fibrotest (1)
- fluorine (1)
- foraminifera (1)
- foraminifers (1)
- forest classification (1)
- forest functional similarity (1)
- fragment-based screening (1)
- functional genetics (1)
- gadobutrol (1)
- gene family (1)
- genetic generalized epilepsy (1)
- genome evolution (1)
- geophysical prospections (1)
- germ cell tumors (1)
- glioblastoma (1)
- glioblastoma survival (1)
- global change (1)
- graft rejection (1)
- graft-versus host (1)
- grasshopper communities (1)
- guidelines (1)
- habitat destruction (1)
- head-and-neck cancer (1)
- health information exchange (1)
- healthcare (1)
- heart failure (1)
- heavy ion experiments (1)
- hepatic encephalopathy (1)
- hepatocellular carcinoma (1)
- high-pitch (1)
- highly-charged ions (1)
- histology (1)
- hospital exemption (1)
- human cytomegalovirus (1)
- human knockout model (1)
- hypertension, pulmonary (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- immunity (1)
- immunohistochemistry (1)
- in vivo dosimetry (1)
- infection control (1)
- integrative taxonomy (1)
- interoperability (1)
- interventional radiology (1)
- intraarterial therapy (1)
- intrinsically disordered region (1)
- invasive species (1)
- iron chelation (1)
- ischemic type biliary lesions (1)
- keratoplasty (1)
- kidney formation (1)
- kinase inhibitor (1)
- knockout mouse (1)
- lamotrigine (1)
- learning (1)
- levetiracetam (1)
- liver fibrosis (1)
- liver metastases (1)
- liver metastasis (1)
- liver transplantation (1)
- livermetastases of colorectal cancer (1)
- local radiotherapy (1)
- locoregional chemotherapy (1)
- long non-coding RNA (1)
- low-dose imaging (1)
- mRNA active cancer immunotherapy (1)
- mRNA vaccine (1)
- mTOR (1)
- mTOR inhibitor (1)
- macrophage (1)
- magnetic gradiometry (1)
- marginal fit (1)
- marker (1)
- medial prefrontal cortex (mPFC) (1)
- memory consolidation and extinction (1)
- mesenchymal stromal cell (1)
- metastasis (1)
- metastatic prostate cancer (1)
- microdosing (1)
- microkeratome (1)
- microlaparoscopy (1)
- micropalaeontology (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- minimally invasive surgery (1)
- molecular characteristics (1)
- mortality (1)
- motility (1)
- multicenter study (1)
- multidetector computed tomography (1)
- multivariate mixed model (1)
- natural products (1)
- necroptosis (1)
- neovascularization, physiologic (1)
- neutralizing antibodies (1)
- nitrogen deposition (1)
- nocardia (1)
- nocardiosis (1)
- non-invasive fibrosis assessment (1)
- non-small cell lung cancer (1)
- nonstructural proteins (1)
- optical coherence tomography (1)
- orthology (1)
- orthopic liver transplantation (1)
- ovary (1)
- p+p collisions (1)
- pIOL (1)
- pediatric (1)
- pediatric patients (1)
- pediatric robotic surgery (1)
- personality (1)
- pharmacoresistance (1)
- phylogenetic community distance (1)
- phylogenetic signal (1)
- point shear wave elastography (1)
- portal vein (1)
- portosystemic shunt (1)
- predictive biomarkers (1)
- prognostic biomarker (1)
- prostate cancer (1)
- prostate cancer (PCa) (1)
- proteins (1)
- proteobacteria (1)
- proteomics (1)
- pseudoexfoliative syndrome (1)
- pulmonary embolism (1)
- pulmonary nocardiosis (1)
- qualitative research (1)
- quality control (1)
- quantum electrodynamics test (1)
- quark gluon plasma (1)
- radiation dosage (1)
- radiation dosimetry (1)
- radiation protection (1)
- radiomics (1)
- rare diseases (1)
- rats (1)
- re-exposure (1)
- rechallenge (1)
- recurrence pattern (1)
- refractory aGvHD (1)
- reintroduction (1)
- relativistic collisions (1)
- renal impairment (1)
- repeatability (1)
- reproducibility (1)
- resistance (1)
- retrospective trial (1)
- rigor (1)
- robotically assisted surgery (1)
- robotics (1)
- schizophrenia (1)
- sea-level indicator (1)
- semi-dry grassland (1)
- sequential ALK-inhibitor therapy (1)
- sex (1)
- shikonin (SHI) (1)
- simplified production (1)
- single subject classification (1)
- smart home (1)
- smart living (1)
- soil nutrients (1)
- song evolution (1)
- spectra (1)
- sphingolipids (1)
- spike protein (1)
- spontaneous portosystemic shunt (1)
- stage II/III colorectal cancer (1)
- standardization (1)
- steroid-resistant aGvHD (1)
- strong Coulomb field (1)
- structural habitat types (1)
- structural proteins (1)
- survival (1)
- temporal classification (1)
- testis (1)
- therapeutic anticoagulation (1)
- thrombopietin receptor agonist (1)
- thrombosis (1)
- tivantinib (1)
- transcranial magnetic stimulation (TMS) (1)
- transient elastography (1)
- transmission (1)
- transplantation (1)
- treatment resistance (1)
- tropical forests (1)
- trust (1)
- trustworthy AI (1)
- tumor microenvironment (1)
- tyrosine kinase inhibitor (TKI) (1)
- urinary tract development (1)
- uveal melanoma (1)
- valproic acid (1)
- variants of concern (1)
- vegetation-plot data (1)
- web of things (1)
- whole-genome sequencing (1)
- x-ray techniques (1)
- zebrafish development (1)
- Öffentlichkeit (1)
- ΔNp63 (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1124)
- Frankfurt Institute for Advanced Studies (FIAS) (995)
- Informatik (925)
- Medizin (166)
- Geowissenschaften (39)
- Institut für Ökologie, Evolution und Diversität (14)
- Biowissenschaften (13)
- Biodiversität und Klima Forschungszentrum (BiK-F) (10)
- Senckenbergische Naturforschende Gesellschaft (8)
- ELEMENTS (7)
Results are presented on event-by-event electric charge fluctuations in central Pb+Pb collisions at 20, 30, 40, 80 and 158 AGeV. The observed fluctuations are close to those expected for a gas of pions correlated by global charge conservation only. These fluctuations are considerably larger than those calculated for an ideal gas of deconfined quarks and gluons. The present measurements do not necessarily exclude reduced fluctuations from a quark-gluon plasma because these might be masked by contributions from resonance decays.
System-size dependence of strangeness production in nucleus-nucleus collisions at √sNN = 17.3 GeV
(2005)
Emission of pi, K, phi and Lambda was measured in near-central C+C and Si+Si collisions at 158 AGeV beam energy. Together with earlier data for p+p, S+S and Pb+Pb, the system-size dependence of relative strangeness production in nucleus-nucleus collisions is obtained. Its fast rise and the saturation observed at about 60 participating nucleons can be understood as onset of the formation of coherent partonic subsystems of increasing size. PACS numbers: 25.75.-q
Production of Lambda and Antilambda hyperons was measured in central Pb-Pb collisions at 40, 80, and 158 A GeV beam energy on a fixed target. Transverse mass spectra and rapidity distributions are given for all three energies. The Lambda/pi ratio at mid-rapidity and in full phase space shows a pronounced maximum between the highest AGS and 40 A GeV SPS energies, whereas the anti-Lambda}/pi ratio exhibits a monotonic increase. PACS numbers: 25.75.-q
Results are presented on Omega production in central Pb+Pb collisions at 40 and 158 AGeV beam energy. Given are transverse-mass spectra, rapidity distributions, and total yields for the sum Omega+Antiomega at 40 AGeV and for Omega and Antiomega separately at 158 AGeV. The yields are strongly under-predicted by the string-hadronic UrQMD model and are in better agreement with predictions from a hadron gas models. PACS numbers: 25.75.Dw
Particle production in central Pb+Pb collisions was studied with the NA49 large acceptance spectrometer at the CERN SPS at beam energies of 20, 30, 40, 80, and 158 GeV per nucleon. A change of the energy dependence is observed around 30A GeV for the yields of pions and strange particles as well as for the shapes of the transverse mass spectra. At present only a reaction scenario with onset of deconfinement is able to reproduce the measurements.
The hadronic final state of central Pb+Pb collisions at 20, 30, 40, 80, and 158 AGeV has been measured by the CERN NA49 collaboration. The mean transverse mass of pions and kaons at midrapidity stays nearly constant in this energy range, whereas at lower energies, at the AGS, a steep increase with beam energy was measured. Compared to p+p collisions as well as to model calculations, anomalies in the energy dependence of pion and kaon production at lower SPS energies are observed. These findings can be explained, assuming that the energy density reached in central A+A collisions at lower SPS energies is sufficient to transform the hot and dense nuclear matter into a deconfined phase.
The hadronic final state of central Pb+Pb collisions at 20, 30, 40, 80, and 158 AGeV has been measured by the CERN NA49 collaboration. The mean transverse mass of pions and kaons at midrapidity stays nearly constant in this energy range, whereas at lower energies, at the AGS, a steep increase with beam energy was measured. Compared to p+p collisions as well as to model calculations, anomalies in the energy dependence of pion and kaon production at lower SPS energies are observed. These findings can be explained, assuming that the energy density reached in central A+A collisions at lower SPS energies is sufficient to force the hot and dense nuclear matter into a deconfined phase.
Introduction: Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) occurs approximately 1 in 3.500 live births representing the most common malformation of the upper digestive tract. Only half a century ago, EA/TEF was fatal among affected newborns suggesting that the steady birth prevalence might in parts be due to mutational de novo events in genes involved in foregut development.
Methods: To identify mutational de novo events in EA/TEF patients, we surveyed the exome of 30 case-parent trios. Identified and confirmed de novo variants were prioritized using in silico prediction tools. To investigate the embryonic role of genes harboring prioritized de novo variants we performed targeted analysis of mouse transcriptome data of esophageal tissue obtained at the embryonic day (E) E8.5, E12.5, and postnatal.
Results: In total we prioritized 14 novel de novo variants in 14 different genes (APOL2, EEF1D, CHD7, FANCB, GGT6, KIAA0556, NFX1, NPR2, PIGC, SLC5A2, TANC2, TRPS1, UBA3, and ZFHX3) and eight rare de novo variants in eight additional genes (CELSR1, CLP1, GPR133, HPS3, MTA3, PLEC, STAB1, and PPIP5K2). Through personal communication during the project, we identified an additional EA/TEF case-parent trio with a rare de novo variant in ZFHX3. In silico prediction analysis of the identified variants and comparative analysis of mouse transcriptome data of esophageal tissue obtained at E8.5, E12.5, and postnatal prioritized CHD7, TRPS1, and ZFHX3 as EA/TEF candidate genes. Re-sequencing of ZFHX3 in additional 192 EA/TEF patients did not identify further putative EA/TEF-associated variants.
Conclusion: Our study suggests that rare mutational de novo events in genes involved in foregut development contribute to the development of EA/TEF.
Tumor cells frequently overexpress heat shock protein 70 (Hsp70) and present it on their cell surface, where it can be recognized by pre‐activated NK cells. In our retrospective study the expression of Hsp70 was determined in relation to tumor‐infiltrating CD56+ NK cells in formalin‐fixed paraffin embedded (FFPE) tumor specimens of patients with SCCHN (N = 145) as potential indicators for survival and disease recurrence. All patients received radical surgery and postoperative cisplatin‐based radiochemotherapy (RCT). In general, Hsp70 expression was stronger, but with variable intensities, in tumor compared to normal tissues. Patients with high Hsp70 expressing tumors (scores 3–4) showed significantly decreased overall survival (OS; p = 0.008), local progression‐free survival (LPFS; p = 0.034) and distant metastases‐free survival (DMFS; p = 0.044), compared to those with low Hsp70 expression (scores 0–2), which remained significant after adjustment for relevant prognostic variables. The adverse prognostic value of a high Hsp70 expression for OS was also observed in patient cohorts with p16‐ (p = 0.001), p53‐ (p = 0.0003) and HPV16 DNA‐negative (p = 0.001) tumors. The absence or low numbers of tumor‐infiltrating CD56+ NK cells also correlated with significantly decreased OS (p = 0.0001), LPFS (p = 0.0009) and DMFS (p = 0.0001). A high Hsp70 expression and low numbers of tumor‐infiltrating NK cells have the highest negative predictive value (p = 0.00004). In summary, a strong Hsp70 expression and low numbers of tumor‐infiltrating NK cells correlate with unfavorable outcome following surgery and RCT in patients with SCCHN, and thus serve as negative prognostic markers.
Increasing atmospheric CO2 stimulates photosynthesis which can increase net primary production (NPP), but at longer timescales may not necessarily increase plant biomass. Here we analyse the four decade-long CO2-enrichment experiments in woody ecosystems that measured total NPP and biomass. CO2 enrichment increased biomass increment by 1.05 ± 0.26 kg C m−2 over a full decade, a 29.1 ± 11.7% stimulation of biomass gain in these early-secondary-succession temperate ecosystems. This response is predictable by combining the CO2 response of NPP (0.16 ± 0.03 kg C m−2 y−1) and the CO2-independent, linear slope between biomass increment and cumulative NPP (0.55 ± 0.17). An ensemble of terrestrial ecosystem models fail to predict both terms correctly. Allocation to wood was a driver of across-site, and across-model, response variability and together with CO2-independence of biomass retention highlights the value of understanding drivers of wood allocation under ambient conditions to correctly interpret and predict CO2 responses.